Respiratory Distress Syndrome
Conditions
Keywords
vitamin D, Respiratory distress syndrome, sepsis, preterm
Brief summary
Experimental and observational studies have shown that vitamin D deficiency may be associated with an increased risk for non-bone diseases and/or abnormal development for the other systems of fetus. The aim of this study is to determine the relationship between cord blood 25-hydroxyvitamin D (25 (OH) D) concentrations and the subsequent risk of morbidities including RDS, PDA, NEC, BPD AND ROP in preterm infants.
Detailed description
It was shown that vitamin D play important role in the pathogenesis of long term morbidities of newborn. Experimental and observational studies have shown that vitamin D deficiency may be associated with an increased risk for non-bone diseases and/or abnormal development for the other systems of fetus. The aim of this study is to determine the relationship between cord blood 25-hydroxyvitamin D (25 (OH) D) concentrations and the subsequent risk of morbidities including RDS, PDA, NEC, BPD AND ROP in preterm infants.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* infants \<32 weeks of gestational age
Exclusion criteria
* infants with major congenital abnormality * infants \>32 weeks of gestational age
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Respiratory Distress Syndrome | three days | The association of vitamin D level with respiratory distress syndrome |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Sepsis | four weeks | Association of vitamin D level with sepsis |
Countries
Turkey (Türkiye)
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Low Vitamin D Level The premature infants with low cord blood vitamin D level | 57 |
| Normal Vitamin D The premature infants with normal vitamin D level | 24 |
| Total | 81 |
Baseline characteristics
| Characteristic | Low Vitamin D Level | Normal Vitamin D | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 57 Participants | 24 Participants | 81 Participants |
| Age, Categorical >=65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical Between 18 and 65 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Continuous | 27.9 weeks STANDARD_DEVIATION 2.4 | 29.2 weeks STANDARD_DEVIATION 1.8 | 28.3 weeks STANDARD_DEVIATION 3.6 |
| Region of Enrollment Turkey | 57 participants | 24 participants | 81 participants |
| Sex: Female, Male Female | 33 Participants | 12 Participants | 45 Participants |
| Sex: Female, Male Male | 24 Participants | 12 Participants | 36 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | — / — | — / — |
| other Total, other adverse events | 0 / 57 | 0 / 24 |
| serious Total, serious adverse events | 0 / 57 | 0 / 24 |
Outcome results
Respiratory Distress Syndrome
The association of vitamin D level with respiratory distress syndrome
Time frame: three days
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Low Vitamin D Level | Respiratory Distress Syndrome | 52 participants |
| Normal Vitamin D | Respiratory Distress Syndrome | 3 participants |
Sepsis
Association of vitamin D level with sepsis
Time frame: four weeks
| Arm | Measure | Value (NUMBER) |
|---|---|---|
| Low Vitamin D Level | Sepsis | 18 participants |
| Normal Vitamin D | Sepsis | 3 participants |